(Q37973897)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22226301%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Melatonin and the metabolic syndrome: a tool for effective therapy in obesity-associated abnormalities? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22226301%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

0 references

0 references

1 reference

Frederic Nduhirabandi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22226301%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

E F du Toit

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22226301%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

A Lochner

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22226301%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

3 February 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22226301%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22226301%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

205

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22226301%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22226301%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

209-223

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22226301%20AND%20SRC:MED&resulttype=core&format=json

Adipocyte differentiation is inhibited by melatonin through the regulation of C/EBPbeta transcriptional activity

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Impaired nocturnal synthesis of melatonin in patients with cardiac syndrome X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

In vivo activation of insulin receptor tyrosine kinase by melatonin in the rat hypothalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Sustained anti-beta-adrenergic effect of melatonin in guinea pig heart papillary muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Pinealectomy and melatonin administration in rats: their effects on plasma leptin levels and relationship with zinc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Regulation of leptin synthesis in white adipose tissue of the female fruit bat, Cynopterus sphinx: role of melatonin with or without insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Physiological and metabolic functions of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Body weight, food intake and energy regulation in exercising and melatonin-treated Siberian hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

The effects of melatonin on burn-induced inflammatory responses and coagulation disorders in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Tissue specificity on insulin action and resistance: past to recent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Insulin and leptin as adiposity signals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Melatonin reduces ventricular arrhythmias and preserves capillary perfusion during ischemia-reperfusion events in cardiomyopathic hamsters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Serum antioxidant status is associated with metabolic syndrome among U.S. adults in recent national surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

The role of SOCS-3 in leptin signaling and leptin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Obesity, insulin resistance and free fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Melatonin: action as antioxidant and potential applications in human disease and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Effects of short-term feed deprivation and melatonin implants on circadian patterns of leptin in the horse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Acute modifications in the levels of daytime melatonin do not influence leptin in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Effect of a high-fat diet on 24-h pattern of circulating levels of prolactin, luteinizing hormone, testosterone, corticosterone, thyroid-stimulating hormone and glucose, and pineal melatonin content, in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Effects of pinealectomy and exogenous melatonin on serum leptin levels in male rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Melatonin and the metabolic syndrome: physiopathologic and therapeutical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Insulin modulates leptin-induced STAT3 activation in rat hypothalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Removal of melatonin receptor type 1 induces insulin resistance in the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Melatonin differentially affects vascular blood flow in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Decreased nocturnal melatonin levels during acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Clinical aspects of melatonin in the acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

The melatonin receptor subtype MT2 is present in the human cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Leptin treatment increases suppressors of cytokine signaling in central and peripheral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Urinary melatonin and risk of incident hypertension among young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Pineal melatonin synthesis is decreased in type 2 diabetic Goto-Kakizaki rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Melatonin receptor-mediated protection against myocardial ischaemia/reperfusion injury: role of its anti-adrenergic actions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Individual and synergistic antioxidative actions of melatonin: studies with vitamin E, vitamin C, glutathione and desferrioxamine (desferoxamine) in rat liver homogenates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Intracoronary melatonin increases coronary blood flow and cardiac function through β-adrenoreceptors, MT1/MT2 receptors, and nitric oxide in anesthetized pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Metabolic syndrome pandemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Melatonin stimulates glucose transport via insulin receptor substrate-1/phosphatidylinositol 3-kinase pathway in C2C12 murine skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Melatonin, hormone of darkness and more: occurrence, control mechanisms, actions and bioactive metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Melatonin--a pleiotropic, orchestrating regulator molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

A novel component of the metabolic syndrome: the oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Reactive oxygen species have a causal role in multiple forms of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Two susceptible diabetogenic variants near/in MTNR1B are associated with fasting plasma glucose in a Han Chinese cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Global burden of obesity in 2005 and projections to 2030.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

The effects of oral melatonin on the autonomic function in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Role of melatonin in metabolic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Leptin beyond body weight regulation--current concepts concerning its role in immune function and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Is red wine a SAFE sip away from cardioprotection? Mechanisms involved in resveratrol- and melatonin-induced cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Short- and long-term effects of melatonin on myocardial post-ischemic recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Melatonin protects the mitochondria from oxidative damage reducing oxygen consumption, membrane potential, and superoxide anion production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Implications of crosstalk between leptin and insulin signaling during the development of diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Loss of melatonin signalling and its impact on circadian rhythms in mouse organs regulating blood glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

A Combination of Melatonin and Alpha Lipoic Acid has Greater Cardioprotective Effect than Either of them Singly Against Cadmium-Induced Oxidative Damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Melatonin receptors in pancreatic islets: good morning to a novel type 2 diabetes gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Mechanisms of leptin action and leptin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Metabolic effects of melatonin on oxidative stress and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Long-term melatonin administration reduces hyperinsulinemia and improves the altered fatty-acid compositions in type 2 diabetic rats via the restoration of Delta-5 desaturase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Effect of pinealectomy on plasma levels of insulin and leptin and on hepatic lipids in type 2 diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Ramelteon attenuates age-associated hypertension and weight gain in spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

The influence of estradiol and progesterone and melatonin supplementation on TNF-alpha levels in ovariectomized and pinealectomized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Melatonin: Nature's most versatile biological signal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

The autonomic nervous system, adipose tissue plasticity, and energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

New evidence for a role of melatonin in glucose regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Melatonin and type 2 diabetes - a possible link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Long‐term enteral administration of melatonin reduces plasma insulin and increases expression of pineal insulin receptors in both Wistar and type 2‐diabetic Goto‐Kakizaki rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Increased susceptibility to Ca(2+)-induced permeability transition and to cytochrome c release in rat heart mitochondria with aging: effect of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Daily rhythm of glucose-induced insulin secretion by isolated islets from intact and pinealectomized rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Ph

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Metabolic syndrome and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Melatonin effect on rat body weight regulation in response to high-fat diet at middle age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Oxidative stress, insulin signaling, and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Daily melatonin administration at middle age suppresses male rat visceral fat, plasma leptin, and plasma insulin to youthful levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

The circadian melatonin rhythm and its modulation: possible impact on hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Melatonin: a multitasking molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Beneficial effects of melatonin in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Cardiac hypertrophy and remodelling: pathophysiological consequences and protective effects of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Obesity and metabolic syndrome: association with chronodisruption, sleep deprivation, and melatonin suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high fat-fed rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Oxidative stress and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Low testosterone levels and unimpaired melatonin secretion in young males with metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Regulation of antioxidant enzymes: a significant role for melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Nocturnal melatonin secretion in thyroid disease and in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Effects of circadian disruption on the cardiometabolic system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Myocardial ischemia-reperfusion in rats: reduction of infarct size by either supplemental physiological or pharmacological doses of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Effects of physiological and pharmacological concentrations of melatonin on ischemia-reperfusion arrhythmias in rats: can the incidence of sudden cardiac death be reduced?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

The effect of myocardial infarction on the synthesis, concentration and receptor expression of endogenous melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

A case-control study of melatonin receptor type 1A polymorphism and acute myocardial infarction in a Spanish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Clinical uses of melatonin: evaluation of human trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Melatonin inhibits fatty acid-induced triglyceride accumulation in ROS17/2.8 cells: implications for osteoblast differentiation and osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Melatonin and estradiol effects on food intake, body weight, and leptin in ovariectomized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Melatonin improves glucose homeostasis and endothelial vascular function in high-fat diet-fed insulin-resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Leptin resistance: a prediposing factor for diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

NEU-P11, a novel melatonin agonist, inhibits weight gain and improves insulin sensitivity in high-fat/high-sucrose-fed rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Melatonin ameliorates high fat diet-induced diabetes and stimulates glycogen synthesis via a PKCzeta-Akt-GSK3beta pathway in hepatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Effects of melatonin administration on plasma leptin concentration and adipose tissue leptin secretion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Therapeutic actions of melatonin in cancer: possible mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Melatonin modulates glucose homeostasis during winter dormancy in a vespertilionid bat, Scotophilus heathi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Obesity, blood vessels and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Melatonin and vitamin C increase umbilical blood flow via nitric oxide-dependent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

MT2 Receptors Mediate the Inhibitory Effects of Melatonin on Nitric Oxide-Induced Relaxation of Porcine Isolated Coronary Arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Melatonin inhibits lipid peroxidation and stimulates the antioxidant status of diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Assessment of the effects of physiological release of melatonin on arterial distensibility and blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Calorie restriction reduces pinealectomy-induced insulin resistance by improving GLUT4 gene expression and its translocation to the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Physiology and pharmacology of melatonin in relation to biological rhythms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X

Effects of melatonin in isolated rat papillary muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2012.02410.X